NYSE:CIM - Chimera Investment Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $10.00
  • Forecasted Upside: -39.14 %
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$16.43
▼ -0.32 (-1.91%)

This chart shows the closing price for CIM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Chimera Investment Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CIM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CIM

Analyst Price Target is $10.00
▼ -39.14% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Chimera Investment in the last 3 months. The average price target is $10.00, with a high forecast of $10.00 and a low forecast of $10.00. The average price target represents a -39.14% upside from the last price of $16.43.

This chart shows the closing price for CIM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 3 investment analysts is to hold stock in Chimera Investment. This rating has held steady since April 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
6/5/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
9/3/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 1 sell ratings
12/2/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 1 sell ratings
3/2/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
5/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
8/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
10/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
11/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/27/2021BTIG ResearchReiterated RatingHoldMedium
4/23/2021BTIG ResearchReiterated RatingHoldLow
2/22/2021Raymond JamesReiterated RatingHoldLow
12/10/2020BarclaysDowngradeEqual Weight ➝ Underweight$9.00 ➝ $10.00Low
12/4/2020Raymond JamesReiterated RatingHoldHigh
11/23/2020BTIG ResearchInitiated CoverageNeutralHigh
8/14/2020Raymond JamesReiterated RatingHoldLow
8/14/2020Royal Bank of CanadaLower Price TargetOutperform$11.00 ➝ $10.00Medium
5/18/2020Royal Bank of CanadaLower Price TargetPositive ➝ Outperform$23.00 ➝ $11.00Low
4/30/2020NomuraReiterated RatingBuy$12.00Medium
4/29/2020BarclaysReiterated RatingHold$20.00 ➝ $9.00Medium
2/25/2020Royal Bank of CanadaReiterated RatingBuy$21.00 ➝ $23.00High
10/2/2019Royal Bank of CanadaInitiated CoverageOutperform$21.00Medium
8/21/2019Credit Suisse GroupDowngradeOutperform ➝ Neutral$19.50High
3/27/2019Nomura SecuritiesInitiated CoverageBuy ➝ Buy$20.00Low
2/13/2019Deutsche Bank AktiengesellschaftDowngradeBuy ➝ HoldMedium
10/24/2018Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$19.00 ➝ $18.50Medium
10/11/2018Raymond JamesInitiated CoverageMarket PerformMedium
8/2/2018Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$20.00Low
6/15/2018Royal Bank of CanadaInitiated CoverageOutperform$20.00Low
2/16/2018Keefe, Bruyette & WoodsReiterated RatingHold$18.00Low
1/31/2018Deutsche Bank AktiengesellschaftUpgradeHold ➝ BuyHigh
1/25/2018Credit Suisse GroupUpgradeNeutral ➝ Outperform$18.01 ➝ $19.00Medium
10/10/2017BarclaysSet Price TargetHold$17.00 ➝ $18.00N/A
10/6/2017Keefe, Bruyette & WoodsReiterated RatingHold$18.50N/A
8/3/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$19.00 ➝ $20.00Low
5/8/2017BarclaysSet Price TargetHold$17.00Low
2/16/2017Wells Fargo & CompanyUpgradeUnderperform ➝ Market PerformN/A
(Data available from 11/27/2016 forward)

News Sentiment Rating

0.45 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/1/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/30/2021
  • 6 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/29/2021
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2021
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2021

Current Sentiment

  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Chimera Investment logo
Chimera Investment Corp. operates as a real estate investment trust. It is engaged in the business of investing in a portfolio of mortgage assets, including residential mortgage loans, Agency RMBS, Non-Agency RMBS, Agency CMBS, and other real estate-related assets The firm's objective is to provide risk-adjusted returns to its investors over the long-term, primarily through dividends and secondarily through capital appreciation. The company was founded on June 1, 2007 and is headquartered in New York, NY.
Read More

Today's Range

Now: $16.43
Low: $16.08
High: $16.58

50 Day Range

MA: $15.78
Low: $14.85
High: $16.80

52 Week Range

Now: $16.43
Low: $9.78
High: $16.85

Volume

1,568,816 shs

Average Volume

1,854,569 shs

Market Capitalization

$3.89 billion

P/E Ratio

5.61

Dividend Yield

7.88%

Beta

0.95

Frequently Asked Questions

What sell-side analysts currently cover shares of Chimera Investment?

The following sell-side analysts have issued research reports on Chimera Investment in the last year: Barclays PLC, BTIG Research, Raymond James, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for CIM.

What is the current price target for Chimera Investment?

1 Wall Street analysts have set twelve-month price targets for Chimera Investment in the last year. Their average twelve-month price target is $10.00, suggesting a possible downside of 39.1%. Barclays PLC has the highest price target set, predicting CIM will reach $10.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $10.00 for Chimera Investment in the next year.
View the latest price targets for CIM.

What is the current consensus analyst rating for Chimera Investment?

Chimera Investment currently has 1 sell rating and 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CIM, but not buy more shares or sell existing shares.
View the latest ratings for CIM.

How do I contact Chimera Investment's investor relations team?

Chimera Investment's physical mailing address is 520 MADISON AVENUE 32ND FLOOR, NEW YORK NY, 10022. The real estate investment trust's listed phone number is (212) 626-2300 and its investor relations email address is [email protected] The official website for Chimera Investment is www.chimerareit.com.